vimarsana.com
Home
Live Updates
Lumos Pharma Announces New Data and Analysis of 15 Subjects
Lumos Pharma Announces New Data and Analysis of 15 Subjects
Lumos Pharma Announces New Data and Analysis of 15 Subjects from OraGrowtH212 Trial Presented at the 2023 ESPE Annual Meeting
Deconvolution Analysis Shows 60% Increase in GH Secretion, Comparable to Established Values in Normal Children Analysis Shows Annualized Height Velocity Increased ~62% Compared to BaselineData Support...
Related Keywords
Russia ,
Netherlands ,
Ukraine ,
Texas ,
United States ,
Lisa Miller ,
Lumos Pharma ,
Johnc Mckew ,
Fernando Cassorla ,
European Society For Paediatric Endocrinology ,
Lumos Pharma Inc ,
Nasdaq ,
Deconvolution Analysis Shows ,
Established Values ,
Normal Children ,
Shows Annualized Height Velocity Increased ,
Pediatric Growth Hormone Deficiency ,
European Society ,
Paediatric Endocrinology ,
Chief Scientific Officer ,
Deconvolution Analysis ,
Local Time ,
Orphan Drug Designation ,
Private Securities Litigation Reform Act ,
Annual Report ,
Media Contact ,
Markets ,